COVID-19: Only updated medicines permitted for treatment

The Kerala High Court was informed by state government on Friday that it has taken a decision to only allow updated medicines for the treatment of novel coronavirus in the state.

The division bench of Justices Raja Vijayaraghavan and TR Ravi was hearing a petition seeking directions for the implementation of AYUSH notification and to permit homoeopathy to treat COVID-19 patients. The petitioner asked for more time to respond following which the High Court posted the matter for further hearing after summer vacation.

The bench told the petitioner that “The Supreme Court has already dismissed a petition which sought direction for permission of Homeopathy treatment for COVID-19. AYUSH Ministry has only suggested alternate medicine for boosting immunity and not as a treatment for COVID-19,” The petitioner said that the revised guidelines issued by the Union Ministry of Home Affairs have included the AYUSH system of medicine as activities permissible after April 20.

Kerala High Court had refused to issue any interim relief or directions on the matter.

The petitioner’s advocate MS Vineeth appearing party-in-person has sought directions to the state to refrain from acting coercively against homoeopathy practitioners treating COVID-19 patients.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid